Herbal medicines in functional dyspepsia—Untapped opportunities not without risks

Contemporary treatments for functional dyspepsia have limitations. Herbal medicine has been suggested as adjunctive treatment. With growing scientific recognition and public interests, an in‐depth review of this is timely.

[1]  S. Grace,et al.  Practice-Based Research in Complementary Medicine: Could N-of-1 Trials Become the New Gold Standard? , 2020, Healthcare.

[2]  J. Tack,et al.  Herbal medicine in the treatment of functional gastrointestinal disorders: A systematic review with meta‐analysis , 2020, Journal of gastroenterology and hepatology.

[3]  J. Tack,et al.  Analysis of Postprandial Symptom Patterns in Subgroups of Patients With Rome III or Rome IV Functional Dyspepsia. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  J. Tack,et al.  The effect of rikkunshito on gastrointestinal symptoms and gastric motor function: The first study in a Belgian functional dyspepsia population , 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[5]  P. Malfertheiner,et al.  Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches , 2019, Digestive Diseases.

[6]  Xudong Tang,et al.  A Combination of Peppermint Oil and Caraway Oil for the Treatment of Functional Dyspepsia: A Systematic Review and Meta-Analysis , 2019, Evidence-based complementary and alternative medicine : eCAM.

[7]  H. Frijlink,et al.  Efficacy and Safety of Peppermint Oil in a Randomized Double-blind Trial of Patients With Irritable Bowel Syndrome. , 2019, Gastroenterology.

[8]  Y. Morine,et al.  Daikenchuto, a traditional Japanese herbal medicine, promotes colonic transit by inducing a propulsive movement pattern , 2019, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[9]  Y. Chawla,et al.  Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients. , 2019, The American journal of gastroenterology.

[10]  Xinzhong Dong,et al.  Effects of ginger constituent 6‐shogaol on gastroesophageal vagal afferent C‐fibers , 2019, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[11]  J. Tack,et al.  Review article: treatment options for functional dyspepsia , 2019, Alimentary pharmacology & therapeutics.

[12]  W. Chey,et al.  A Novel, Duodenal-Release Formulation of a Combination of Caraway Oil and L-Menthol for the Treatment of Functional Dyspepsia: A Randomized Controlled Trial , 2019, Clinical and translational gastroenterology.

[13]  Chunjie Wu,et al.  Comparative studies on the regulatory effects of raw and charred hawthorn on functional dyspepsia and intestinal flora , 2019, Tropical Journal of Pharmaceutical Research.

[14]  Hai-juan Wang,et al.  Heavy metal pollution and potential health risks of commercially available Chinese herbal medicines. , 2019, The Science of the total environment.

[15]  K. Obama,et al.  Rikkunshito for upper gastrointestinal symptoms: A systematic review and meta-analysis. , 2019, Complementary therapies in medicine.

[16]  B. Kuo,et al.  Gastroparesis and Functional Dyspepsia: A Blurring Distinction of Pathophysiology and Treatment , 2019, Journal of Neurogastroenterology and Motility.

[17]  Zhaoshen Li,et al.  The efficacy of oral Zhizhu Kuanzhong, a traditional Chinese medicine, in patients with postprandial distress syndrome , 2018, Journal of gastroenterology and hepatology.

[18]  Traditional Chinese Medicine : A Statement by EASAC and FEAM , 2019 .

[19]  The World Health Organization’s decision about traditional Chinese medicine could backfire , 2019, Nature.

[20]  N. Talley,et al.  Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors , 2018, Digestive Diseases and Sciences.

[21]  Yao-jun Wang,et al.  Effect of Zhizhu Kuanzhong Capsules (枳术宽中胶囊) on Treatment of Functional Dyspepsia: A Meta-Analysis of Randomized Controlled Trials , 2018, Chinese Journal of Integrative Medicine.

[22]  Yousef Nassar,et al.  Proton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis , 2018, Journal of bone metabolism.

[23]  H. Kusunoki,et al.  Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: A randomized clinical trial (the DREAM study) , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[24]  N. Talley,et al.  Inconsistent symptom clusters for functional gastrointestinal disorders in Asia: is Rome burning? , 2018, Gut.

[25]  S. Miehlke,et al.  Effectiveness of Menthacarin on symptoms of irritable bowel syndrome , 2018, Wiener Medizinische Wochenschrift.

[26]  X. Hou,et al.  Tu1586 - Traditional Chinese Medicine Zhizhu-Kuanzhong Modulates the Gastric Motility and Sensation Contributing to the Effective Relief from Functional Dyspepsia , 2018 .

[27]  W. Whitehead,et al.  Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. , 2018, The lancet. Gastroenterology & hepatology.

[28]  C. Sadakane,et al.  Influence of food on the gastric motor effect of the Kampo medicine rikkunshito in rat , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[29]  R. Teschke,et al.  Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury , 2017, Journal of clinical and translational hepatology.

[30]  N. Koloski,et al.  A randomized placebo‐controlled trial on the effects of Menthacarin, a proprietary peppermint‐ and caraway‐oil‐preparation, on symptoms and quality of life in patients with functional dyspepsia , 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[31]  Lin Lv,et al.  Efficacy and safety of Xiangsha Liujunzi granules for functional dyspepsia: A multi-center randomized double-blind placebo-controlled clinical study , 2017, World journal of gastroenterology.

[32]  W. Whitehead,et al.  Rome foundation Asian working team report: Real world treatment experience of Asian patients with functional bowel disorders , 2017, Journal of gastroenterology and hepatology.

[33]  W. Whitehead,et al.  Rome Foundation-Asian working team report: Asian functional gastrointestinal disorder symptom clusters , 2017, Gut.

[34]  J. Gribben,et al.  Chronic lymphocytic leukaemia , 2017, Nature Reviews Disease Primers.

[35]  G. Boeckxstaens,et al.  Functional dyspepsia , 2017, Nature Reviews Disease Primers.

[36]  J. Tack,et al.  Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria , 2017, The American Journal of Gastroenterology.

[37]  Yuefei Wang,et al.  Phytochemical and Pharmacological Studies on the Genus Psoralea: A Mini Review , 2016, Evidence-based complementary and alternative medicine : eCAM.

[38]  E. Sáez-González,et al.  Iberogast-Induced Severe Hepatotoxicity Leading to Liver Transplantation , 2016, The American Journal of Gastroenterology.

[39]  Peicai Li,et al.  Effect of Aurantii Fructus Immaturus Flavonoid on the Contraction of Isolated Gastric Smooth Muscle Strips in Rats , 2016, Evidence-based complementary and alternative medicine : eCAM.

[40]  Jan Tack,et al.  Gastroduodenal Disorders. , 2016, Gastroenterology.

[41]  T. Hibi,et al.  Association of baseline plasma des‐acyl ghrelin level with the response to rikkunshito in patients with functional dyspepsia , 2016, Journal of gastroenterology and hepatology.

[42]  Li Yan,et al.  Clinical study of Zhizhu Kuanzhong capsule in treatment of patients with functional dyspepsia complicated with anxiety and depression , 2016 .

[43]  T. Azuma,et al.  Rikkunshito Ameliorates Cancer Cachexia Partly through Elevation of Glucarate in Plasma , 2015, Evidence-based complementary and alternative medicine : eCAM.

[44]  Lisa J. McQuay,et al.  Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study , 2015, Drug Safety.

[45]  A. Inui,et al.  Pharmacokinetic Profiles of Active Ingredients and Its Metabolites Derived from Rikkunshito, a Ghrelin Enhancer, in Healthy Japanese Volunteers: A Cross-Over, Randomized Study , 2015, PloS one.

[46]  K. Yakabi,et al.  Ghrelin enhancer, rikkunshito, improves postprandial gastric motor dysfunction in an experimental stress model , 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[47]  Tian Wang,et al.  The Efficacy of Shugan Jianpi Zhixie Therapy for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials , 2015, PloS one.

[48]  N. Talley,et al.  Herbal medicines for the treatment of functional and inflammatory bowel disorders. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[49]  P. Barnes,et al.  Trends in the use of complementary health approaches among adults: United States, 2002-2012. , 2015, National health statistics reports.

[50]  Y. Uezono,et al.  Rikkunshito, a ghrelin potentiator, ameliorates anorexia–cachexia syndrome , 2014, Front. Pharmacol..

[51]  Y. Uezono,et al.  Enhancement of catecholamine release from PC12 cells by the traditional Japanese medicine, rikkunshito , 2014, BMC Complementary and Alternative Medicine.

[52]  F. Cremonini.  Standardized herbal treatments on functional bowel disorders: moving from putative mechanisms of action to controlled clinical trials , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[53]  T. Hibi,et al.  Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia—a multicenter, double‐blind, randomized, placebo‐controlled study , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[54]  P. Zhao,et al.  Acute Liver Failure Associated With Traditional Chinese Medicine: Report of 30 Cases From Seven Tertiary Hospitals in China* , 2014, Critical care medicine.

[55]  T. Oka,et al.  Effects of Kampo on functional gastrointestinal disorders , 2014, BioPsychoSocial Medicine.

[56]  Baolin Wang,et al.  Causes and Outcomes of Acute Liver Failure in China , 2013, PloS one.

[57]  Pau-Chung Chen,et al.  Concurrent Use of Conventional Drugs with Chinese Herbal Products in Taiwan: A Population-based Study , 2013, Journal of traditional and complementary medicine.

[58]  M. Cicala,et al.  A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders , 2013, United European gastroenterology journal.

[59]  Luqing Zhao,et al.  Efficacy of modified LiuJunZi decoction on functional dyspepsia of spleen-deficiency and qi-stagnation syndrome: a randomized controlled trial , 2013, BMC Complementary and Alternative Medicine.

[60]  P. Malfertheiner,et al.  STW 5 (Iberogast®)—a safe and effective standard in the treatment of functional gastrointestinal disorders , 2012, Wiener Medizinische Wochenschrift.

[61]  Mingzi Ouyang,et al.  Meta-Analysis of Randomized Controlled Trials , 2012 .

[62]  K. Tominaga,et al.  The Traditional Japanese Medicine Rikkunshito Promotes Gastric Emptying via the Antagonistic Action of the 5-HT3 Receptor Pathway in Rats , 2011, Evidence-based complementary and alternative medicine : eCAM.

[63]  W. Hsu,et al.  Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis. , 2010, British journal of clinical pharmacology.

[64]  R. Langer,et al.  The multi‐herbal drug STW 5 (Iberogast®) has prosecretory action in the human intestine , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[65]  P. Moayyedi,et al.  Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis , 2008, BMJ : British Medical Journal.

[66]  P. Malfertheiner,et al.  STW 5, a Phytopharmacon for Patients With Functional Dyspepsia: Results of a Multicenter, Placebo-Controlled Double-Blind Study , 2007, The American Journal of Gastroenterology.

[67]  Tzeng-Ji Chen,et al.  Use frequency of traditional Chinese medicine in Taiwan , 2007, BMC Health Services Research.

[68]  P. Enck,et al.  STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[69]  M. Schemann,et al.  Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[70]  O. Kelber,et al.  Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[71]  L. Bechmann,et al.  A combination of peppermint oil and caraway oil attenuates the post-inflammatory visceral hyperalgesia in a rat model , 2006, Scandinavian journal of gastroenterology.

[72]  Yueh-Ching Chou,et al.  Drug utilization pattern of Chinese herbal medicines in a general hospital in Taiwan , 2005, Pharmacoepidemiology and drug safety.

[73]  Chih‐Yen Chen,et al.  Prevalence and health/social impacts of functional dyspepsia in Taiwan: A study based on the Rome Criteria Questionnaire Survey assisted by endoscopic exclusion among a physical check-up population , 2005, Scandinavian journal of gastroenterology.

[74]  D. Schuppan,et al.  Herbal hepatotoxicity. , 2005, Journal of hepatology.

[75]  B. Göke,et al.  Herbal Extracts Modulate the Amplitude and Frequency of Slow Waves in Circular Smooth Muscle of Mouse Small Intestine , 2005, Digestion.

[76]  O. Kelber,et al.  The herbal preparation STW5 (lberogast®) has potent and region‐specific effects on gastric motility , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[77]  J. Tack,et al.  Impact of Coexisting Irritable Bowel Syndrome on Symptoms and Pathophysiological Mechanisms in Functional Dyspepsia , 2004, American Journal of Gastroenterology.

[78]  G. Holtmann,et al.  Treatment of Functional Dyspepsia with a Herbal Preparation , 2004, Digestion.

[79]  G. Holtmann,et al.  Treatment of irritable bowel syndrome with herbal preparations: results of a double‐blind, randomized, placebo‐controlled, multi‐centre trial , 2004, Alimentary pharmacology & therapeutics.

[80]  Xu Cui-ping.  Evaluation of Zhizhukuanzhong capsule in treatment of functional dyspepsia in 403 patients:a phase II clinical trial , 2004 .

[81]  H. Lang,et al.  Current patterns of irritable bowel syndrome in Taiwan: the Rome II questionnaire on a Chinese population , 2003, Alimentary pharmacology & therapeutics.

[82]  G. Holtmann,et al.  Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six‐week placebo‐controlled, double‐blind, multicentre trial , 2003, Alimentary pharmacology & therapeutics.

[83]  N. Talley,et al.  Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia , 2003, Alimentary pharmacology & therapeutics.

[84]  O. Jung,et al.  Effects of intraduodenal application of peppermint oil (WS® 1340) and caraway oil (WS® 1520) on gastroduodenal motility in healthy volunteers , 2003, Phytotherapy research : PTR.

[85]  T. Spilker,et al.  Effect of peppermint oil and caraway oil on gastrointestinal motility in healthy volunteers: a pharmacodynamic study using simultaneous determination of gastric and gall‐bladder emptying and orocaecal transit time , 2003, Alimentary pharmacology & therapeutics.

[86]  Ding‐Shinn Chen,et al.  A hospital-based study on the use of alternative medicine in patients with chronic liver and gastrointestinal diseases. , 2002, The American journal of Chinese medicine.

[87]  W. Stalman,et al.  Consultations and referrals for dyspepsia in general practice—a one year database survey , 2001, Postgraduate medical journal.

[88]  I. Sassin,et al.  [A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study]. , 2001, Zeitschrift fur Gastroenterologie.

[89]  S. Köhler,et al.  Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia , 2000, Alimentary pharmacology & therapeutics.

[90]  G. Micklefield,et al.  Effects of peppermint oil and caraway oil on gastroduodenal motility , 2000, Phytotherapy research : PTR.

[91]  G. Komaki,et al.  Trial of Liu Jun Zi Tang as an Initial Treatment for Anorexia Nervosa , 1995 .

[92]  D. Triggle,et al.  The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations , 1988, Alimentary pharmacology & therapeutics.